Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging - Relation to clinical characteristics in subgroups of patients with multiplesclerosis
Maa. Van Walderveen et al., Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging - Relation to clinical characteristics in subgroups of patients with multiplesclerosis, ARCH NEUROL, 58(1), 2001, pp. 76-81
Context: Hypointense lesions on T1-weighted spin-echo magnetic resonance im
ages (T1 lesions) represent destructive multiple sclerosis (MS) lesions, co
nsisting of axonal loss and matrix destruction. These lesions are being use
d as a secondary outcome measure in phase III clinical trials. Clinical det
erminants of T1 lesions may differ between subgroups of patients with MS an
d subsequently may have implications for the selection of patients for clin
ical trials.
Objective: To determine if clinical characteristics of patients with MS are
related to T1 lesion volume.
Design: A survey of 138 patients with MS (52 with relapsing-remitting MS, 4
4 with secondary progressive MS, and 42 with primary progressive MS).
Setting: The Magnetic Resonance Center for Multiple Sclerosis Research, Uni
versity Hospital "Vrije Universiteit," Amsterdam, the Netherlands.
Main Outcome Measures: Type of MS, Expanded Disability) Status Scale (EDSS)
score, sex, age at first symptoms, and T1 lesion volume.
Results: Patients with secondary progressive MS have the highest T1 lesion
volume, patients with relapsing-remitting MS have a lower T1/T2 ratio than
patients with secondary progressive MS and patients with primary progressiv
e MS. In patients with relapsing-remitting MS and secondary progressive MS,
T1 lesion volume relates to disease duration and EDSS score, while in pati
ents with primary progressive MS sex is important. A trend toward higher T1
lesion volume was shown for male patients with primary progressive MS when
compared with female patients with primary progressive MS (1.0 cm(3) vs 0.
3 cm(3), P=.03); a trend toward higher T1 lesion volume was found with age
at onset in patients with relapsing-remitting MS and in patients with prima
ry progressive MS.
Conclusions: In patients with MS different clinical characteristics associa
te with T1 lesion volume, suggesting a more destructive type of lesions in
certain subgroups. A possible sex difference in (destructive) lesion develo
pment on magnetic resonance imaging should be evaluated in more detail, pre
ferably in a cohort.